KWALITY PHARMACEUTICALS
Back to Cashflow Statement
|
KWALITY PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-17 Cr | ₹0.99 Cr | ₹5.66 Cr | ₹0.77 Cr | ₹12 Cr |
What is the latest Cash Flow from Financing Activities ratio of KWALITY PHARMACEUTICALS ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-17 Cr |
Mar2023 | ₹0.99 Cr |
Mar2022 | ₹5.66 Cr |
Mar2021 | ₹0.77 Cr |
Mar2020 | ₹12 Cr |
How is Cash Flow from Financing Activities of KWALITY PHARMACEUTICALS Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-17 Cr | Negative | |
Mar2023 | ₹0.99 Cr | -82.43 | |
Mar2022 | ₹5.66 Cr | 637.55 | |
Mar2021 | ₹0.77 Cr | -93.48 | |
Mar2020 | ₹12 Cr | - |
Compare Cash Flow from Financing Activities of peers of KWALITY PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KWALITY PHARMACEUTICALS | ₹739.3 Cr | -5.9% | -19.9% | 34.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹400,617.0 Cr | -2.1% | -9% | 9.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹158,655.0 Cr | 2.4% | 2.2% | 59.7% | Stock Analytics | |
CIPLA | ₹119,511.0 Cr | 1.4% | 2% | 0.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹104,734.0 Cr | -0.9% | -2.8% | 16.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,705.1 Cr | -2.1% | -9.2% | -8.7% | Stock Analytics |
KWALITY PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KWALITY PHARMACEUTICALS | -5.9% |
-19.9% |
34.9% |
SENSEX | -0.4% |
-1.4% |
5.4% |
You may also like the below Video Courses